摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,3-吡啶二甲醛 | 4663-93-8

中文名称
2,3-吡啶二甲醛
中文别名
——
英文名称
pyridine-2,3-dicarbaldehyde
英文别名
2,3-Diformyl-pyridin;Pyridin-2,3-dialdehyd
2,3-吡啶二甲醛化学式
CAS
4663-93-8
化学式
C7H5NO2
mdl
——
分子量
135.122
InChiKey
OYBLXLFKRJWZJG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    277.4±25.0 °C(Predicted)
  • 密度:
    1.274±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.1
  • 重原子数:
    10
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    47
  • 氢给体数:
    0
  • 氢受体数:
    3

SDS

SDS:5964880fdab24c122a9053188a65d300
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2,3-吡啶二甲醛一水合肼 作用下, 以 二氯甲烷 为溶剂, 反应 12.0h, 以534 mg的产率得到吡啶并[2,3-d]哒嗪
    参考文献:
    名称:
    银催化 1,2-二嗪和硅氧基炔烃的形式逆电子需狄尔斯-阿尔德反应
    摘要:
    已经开发出一种高效的银催化 1,2-二嗪和甲硅烷氧基炔的形式逆电子需求狄尔斯-阿尔德反应。这些反应可以方便地获得各种甲硅烷氧基萘和蒽,这些化合物可以在温和的反应条件下使用低催化剂负载量以良好到高的产率形成。
    DOI:
    10.1021/ja302537j
  • 作为产物:
    描述:
    2,3-吡啶二甲酸二甲酯 在 selenium(IV) oxide 、 sodium tetrahydroborate 作用下, 以 1,4-二氧六环 为溶剂, 反应 4.0h, 生成 2,3-吡啶二甲醛
    参考文献:
    名称:
    Coplanar Tetracyclic π‐Excess σ 2 P Ligands
    摘要:
    AbstractThe acid‐catalyzed reactions of 5‐methyl‐2‐phosphanylaniline (1) with dialdehydes were studied. Whereas the reaction with glyoxal provides a mixture of two 1H‐1,3‐benzazaphospholes, 2 and 3, by concomitant reduction of a CHO group and C–C bond cleavage, respectively, the reaction with o‐phthalic dicarbaldehyde provided in excellent yield the tetracyclic planar benzazaphosphole 4, which was characterized by crystal structure analysis. The active hydrogen atoms, delivered by aromatization of a dihydrobenzazaphosphole intermediate, forms an N–CH2 bridge by reductive N‐alkylation. Pyridine‐2,6‐dicarbaldehyde reacts analogously but not chemoselectively and, thus, gives two isomers 5 and 6. Condensation with pyridine‐2,6‐dicarbaldehyde afforded the bis(benzazaphosphole)pyridine pincer ligand 7, but along with 2‐(benzazaphospholyl)‐6‐tolylpyridine (8) by partial P–C bond cleavage. The high upfield 31P NMR chemical shift of 4 compared to those of normal benzazaphospholes indicates it to be a particularly π‐rich σ2P ligand.
    DOI:
    10.1002/ejic.201300342
点击查看最新优质反应信息

文献信息

  • Method and compositions for identifying anti-HIV therapeutic compounds
    申请人:Arimilli N. Murty
    公开号:US20050239054A1
    公开(公告)日:2005-10-27
    Methods are provided for identifying anti-HIV therapeutic compounds substituted with carboxyl ester or phosphonate ester groups. Libraries of such compounds are screened optionally using the novel enzyme GS-7340 Ester Hydrolase. Compositions and methods relating to GS-7340 Ester Hydrolase also are provided.
    提供了一种识别含有羧酸酯或磷酸酯基团取代的抗HIV治疗化合物的方法。可以选择使用新型酶GS-7340酯水解酶对这类化合物库进行筛选。还提供了与GS-7340酯水解酶相关的组合物和方法。
  • [EN] COMPOSITION FOR TIN-SILVER ALLOY ELECTROPLATING COMPRISING A COMPLEXING AGENT<br/>[FR] COMPOSITION POUR L'ÉLECTROGALVANISATION D'ALLIAGE D'ÉTAIN ET D'ARGENT COMPRENANT UN AGENT COMPLEXANT
    申请人:BASF SE
    公开号:WO2019185468A1
    公开(公告)日:2019-10-03
    An aqueous composition comprising (a) metal ions comprising tin ions and silver ions and (b) at least one complexing agent of formula (C1) R1-X1-S-X21[D1-X22-]nS-X3-R2, (C2) R1-X1-S-X31-D2-[X32-S-]nX3-R2, (C3) R3-X1-S-X41-[D3-X42-]nS-X3-R4 wherein X1, X3 are independently selected from a linear or branched C1-C12 alkanediyl, which may be unsubstituted or substituted by OH; X21, X22 are independently selected from X1, which may be further substituted by -X5-COOR12, -X5-SO2-O-R12, a C2 to C6 polyoxyalkylene group of formula -(O-CH2- CHR11)z-OH, or a combination thereof, and -X1-NH-CO-X6-CO-NH-X1-; X31, X32 are independently selected from a chemical bond and X1; X41, X42 are independently selected from X1; X5 is a linear or branched Ci to C10 alkyl; X6 is selected from X1 and a divalent 5 or 6 membered aromatic group; R1, R2 are independently selected from a monovalent 5 or 6 membered aromatic N- heterocyclic group comprising one N atom or two N atoms which are separated by at least one C atom, and its derivatives received by N-alkylation with a C1-C6- alkyl group, which may be substituted by --COOR12 or -SO2-O-R12, and which aromatic N- heterocyclic group may optionally further comprise, under the proviso that X21 is substituted by at least one OH, one S atom; R3, R4 are independently selected from a monovalent 5 or 6 membered aliphatic N- heterocyclic group comprising one N atom and one O atom; D1 is independently selected from S, O and NR10-; D2 is (a) a divalent 5 or 6 membered aliphatic heterocyclic ring system comprising 1 or 2 S atoms, or (b) a 5 or 6 membered aromatic heterocyclic ring system comprising at least two N atoms and optionally one or two S atoms; D3 is independently selected from S and NR10-; n is an integer of from 0 to 5; z is an integer from 1 to 50; R10 is selected from H and a linear or branched C1-C12 alkyl; R11 is selected from H and a linear or branched C1 to C6 alkyl; and R12 is selected from R10 and a cation.
    一种水性组合物,包括(a)包括锡离子和银离子的金属离子和(b)至少一种具有以下结构的络合剂:(C1)R1-X1-S-X21[D1-X22-]nS-X3-R2,(C2)R1-X1-S-X31-D2-[X32-S-]nX3-R2,(C3)R3-X1-S-X41-[D3-X42-]nS-X3-R4,其中X1、X3可独立地选择自线性或支链的C1-C12脂肪二亚基,可以未取代或被OH取代;X21、X22可独立地选择自X1,可以进一步被-X5-COOR12,-X5-SO2-O-R12,具有式-(O-CH2-CHR11)z-OH的C2到C6聚氧烷基,或其组合物取代,以及-X1-NH-CO-X6-CO-NH-X1-;X31、X32可独立地选择自化学键和X1;X41、X42可独立地选择自X1;X5是线性或支链的Ci到C10烷基;X6选择自X1和双价的5或6元芳香族基;R1、R2可独立地选择自包括一个N原子或两个N原子的单价5或6元芳香N-杂环基,通过N-烷基化与C1-C6烷基基团取代的衍生物,可以被--COOR12或-SO2-O-R12取代,该芳香N-杂环基可以选择性地进一步包括,在X21至少被一个OH取代的条件下,一个S原子;R3、R4可独立地选择自包括一个N原子和一个O原子的单价5或6元脂肪N-杂环基;D1可独立地选择自S、O和NR10-;D2是(a)包括1或2个S原子的双价5或6元脂肪杂环环系统,或(b)包括至少两个N原子和可选地一个或两个S原子的5或6元芳香杂环环系统;D3可独立地选择自S和NR10-;n是从0到5的整数;z是从1到50的整数;R10选择自H和线性或支链的C1-C12烷基;R11选择自H和线性或支链的C1到C6烷基;R12选择自R10和阳离子。
  • Synthesis and antibacterial activity of pyrroloaryl-substituted oxazolidinones
    作者:Steven D. Paget、Barbara D. Foleno、Christine M. Boggs、Raul M. Goldschmidt、Dennis J. Hlasta、Michele A. Weidner-Wells、Harvey M. Werblood、Ellyn Wira、Karen Bush、Mark J. Macielag
    DOI:10.1016/j.bmcl.2003.08.031
    日期:2003.12
    A novel series of oxazolidinones containing a pyrroloaryl substituent was synthesized and screened against a representative panel of susceptible and resistant Gram-positive bacteria. Several members of this series were found to have antibacterial activity comparable to or better than linezolid.
    合成了一系列新的含吡咯并芳基取代基的恶唑烷酮,并针对代表性的易感和耐药革兰氏阳性细菌进行了筛选。发现该系列的几个成员具有与利奈唑胺相当或更好的抗菌活性。
  • Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
    申请人:——
    公开号:US20020161029A1
    公开(公告)日:2002-10-31
    Bicyclic heterocyclic substituted phenyl oxazolidinone compounds of the formula: 1 wherein Y is a radical of Formulae II or III: 2 in which the substituents have the meaning indicated in the description. These compounds are useful as antibacterial agents.
    具有以下结构的双环杂环取代苯基噁唑啉酮化合物:其中Y是Formulae II或III的基团:其中取代基具有描述中指示的含义。这些化合物可用作抗菌剂。
  • Aza-isoindolo and isoindolo-azaquinoxaline derivatives with antiproliferative activity
    作者:Barbara Parrino、Anna Carbone、Virginia Spanò、Alessandra Montalbano、Daniele Giallombardo、Paola Barraja、Alessandro Attanzio、Luisa Tesoriere、Claudia Sissi、Manlio Palumbo、Girolamo Cirrincione、Patrizia Diana
    DOI:10.1016/j.ejmech.2015.03.009
    日期:2015.4
    Three new ring systems, pyrido[2′,3′:3,4]pyrrolo[1,2-a]quinoxalines, pyrido[3′,2′:3,4]pyrrolo[1,2-a]quinoxalines and pyrido[2′,3′:5,6]pyrazino[2,1-a]isoindoles, were synthesized through an aza-substitution on the already active isoindolo-quinoxaline system and in particular in the position 7 or 4 of the isoindole moiety and in position 5 of the quinoxaline portion. All new compounds were screened by
    三种新的环系统,吡啶并[2',3':3,4]吡咯并[1,2- a ]喹喔啉,吡啶并[3',2':3,4]吡咯并[1,2- a ]喹喔啉和吡啶[2',3':5,6]吡嗪并[2,1- a ]异吲哚是通过在已经具有活性的异吲哚并喹喔啉系统上,特别是在异吲哚部分的7或4位和在喹喔啉部分的位置5。所有新化合物均由美国国家癌症研究所(Bethesda,MD)针对60种人类肿瘤细胞系进行了筛选。pGI 50活性最高的衍生物的生物学结果值在7.09至7.27之间,证实了甲氧基取代基的存在对于生物活性的重要性。所选喹喔啉的抗增殖作用与细胞凋亡和细胞周期的G2 / M期停滞有关。还评估了化合物的DNA结合特性,以研究可能的作用机理。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
hnmr
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-